How will patients be transitioned from their non-covered drug to a formulary drug?
CMS has issued guidelines that require plans to develop policies that set out clear guidelines and timelines for providers to choose alternate, covered drugs for their patients, or to seek exceptions where appropriate. Each plan should provide its transition policy to its network pharmacies and other providers.
